Insider Trading Alert - Boston Scientific And 3 Others Traded By Insiders

Yesterday, July 5, 2013, 389 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $200.00 to $15,089,002.16.

Highlighted Stocks Traded by Insiders:

Boston Scientific (BSX) - FREE Research Report

Prange Karen who is SVP&Pres, Uro & Women's Health at BOSTON SCIENTIF bought 35,294 shares at $3.06 per share for a total value of $77,321.44 on July 2, 2013. Following this transaction, the SVP&Pres, Uro & Women's Health owned 44,292 shares meaning that the stake was boosted by 136.47% with the 35,294 share acquisition.

The shares most recently traded at $9.30, up $0.15, or 1.64% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 10,941
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 60,058
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 60,058

The average volume for Boston Scientific has been 19.0 million shares per day over the past 30 days. Boston Scientific has a market cap of $12.4 billion and is part of the health care sector and health services industry. Shares are up 60.03% year to date as of the close of trading on Wednesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)